ResearcherRadboud University Medical CenterActive in the last 2 years
John J. Hermans
Matched on OpenAlex author ID A5111976240. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2017: 1 trial · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 3 papers
Papers 3
- Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00261-026-05420-5↗
- Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, … Co-author DOI 10.1016/s1470-2045(25)00567-4↗
- AI-assisted screening for pancreatic cancer – Authors' reply Co-author DOI 10.1016/s1470-2045(26)00054-9↗
Trials 1
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- HenkJan J. Huisman · 2 shared papers, 1 shared trial, 2017–2026 · strength 0.92
- Paper AI-assisted screening for pancreatic cancer – Authors' reply DOI 10.1016/s1470-2045(26)00054-9↗
- Paper Quantitative CT Perfusion as a prognostic biomarker for chemotherapy response in patients with pancreatic ductal adenoc… DOI 10.1007/s00261-026-05420-5↗
- Trial Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics NCT05669287↗
- Natália Alves · 2 shared papers, 2026 · strength 0.75
- Megan Schuurmans · 1 shared paper, 2026 · strength 0.43
- Geke Litjens · 1 shared paper, 2026 · strength 0.32
- T. H. Perik · 1 shared paper, 2026 · strength 0.32
- Erwin J. M. van Geenen · 1 shared paper, 2026 · strength 0.32
- Martijn W.J. Stommel · 1 shared paper, 2026 · strength 0.32
- Lodewijk A.A. Brosens · 1 shared trial, 2017 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.